Catalyst Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	578.2	491.73	398.2	214.2	140.83	119.07
Revenue Growth (YoY)	25.56%	23.49%	85.90%	52.10%	18.27%	16.39%
Cost of Revenue	97.52	81.49	145.12	54.18	38.82	33.54
Gross Profit	480.67	410.24	253.09	160.02	102.01	85.54
Selling, General & Admin	184.52	177.74	133.71	57.09	49.63	44.23
Amortization of Goodwill & Intangibles	37.38	37.38	32.57	1.1	-	-
Operating Expenses	221.9	215.12	166.28	58.18	49.63	44.23
Operating Income	258.78	195.12	86.81	101.84	52.39	41.3
Interest & Investment Income	22.7	16.06	4.68	-	0.28	0.59
Other Non Operating Income (Expenses)	-	-	-	2.88	-	-
EBT Excluding Unusual Items	281.47	211.19	91.49	104.72	52.67	41.89
Gain (Loss) on Sale of Investments	4.33	5.08	3.02	-	-	-
Pretax Income	285.8	216.26	94.51	104.72	52.67	41.89
Income Tax Expense	68.23	52.37	23.1	21.64	13.19	-33.09
Net Income	217.56	163.89	71.41	83.08	39.48	74.98
Net Income to Common	217.56	163.89	71.41	83.08	39.48	74.98
Net Income Growth	52.36%	129.50%	-14.05%	110.42%	-47.34%	135.24%
Shares Outstanding (Basic)	122	118	106	103	103	104
Shares Outstanding (Diluted)	127	125	114	111	108	106
Shares Change (YoY)	4.21%	9.84%	2.14%	3.32%	1.46%	0.21%
EPS (Basic)	1.79	1.38	0.67	0.80	0.38	0.72
EPS (Diluted)	1.71	1.31	0.63	0.75	0.37	0.71
EPS Growth	44.94%	107.94%	-16.00%	102.70%	-47.89%	136.67%
Free Cash Flow	234.54	239.25	-54.92	106.02	59.35	45.02
Free Cash Flow Per Share	1.85	1.92	-0.48	0.95	0.55	0.42
Gross Margin	83.13%	83.43%	63.56%	74.70%	72.44%	71.84%
Operating Margin	44.76%	39.68%	21.80%	47.54%	37.20%	34.69%
Profit Margin	37.63%	33.33%	17.93%	38.78%	28.04%	62.97%
Free Cash Flow Margin	40.56%	48.66%	-13.79%	49.49%	42.14%	37.81%
EBITDA	296.57	232.9	119.69	103.08	52.58	41.4
EBITDA Margin	51.29%	47.36%	30.06%	48.12%	37.33%	34.76%
D&A For EBITDA	37.79	37.77	32.88	1.24	0.19	0.09
EBIT	258.78	195.12	86.81	101.84	52.39	41.3
EBIT Margin	44.76%	39.68%	21.80%	47.54%	37.20%	34.69%
Effective Tax Rate	23.87%	24.22%	24.44%	20.66%	25.04%	-
Revenue as Reported	578.2	491.73	398.2	214.2	140.83	119.07
Advertising Expenses	-	10	9.1	3.3	2.9	2.5

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q